Skip to Content Facebook Feature Image

Lisen Launched the NO.1 Retractable Car Chargers Series on Amazon

Business

Lisen Launched the NO.1 Retractable Car Chargers Series on Amazon
Business

Business

Lisen Launched the NO.1 Retractable Car Chargers Series on Amazon

2025-02-03 22:00 Last Updated At:22:25

NEW YORK, Feb. 3, 2025 /PRNewswire/ -- As one of the leading global market leaders in mobile accessories, Lisen is constantly at the forefront of the market and product innovation. Whether you're relying on your phone for navigation or music, a good car mount can keep it safe and within reach. But don't stop there—keeping your devices fully charged and ready for anything is crucial, especially during long trips. This is the inspiration behind Lisen's series of car chargers and accessories. Now, Lisen has launched a series of innovative retractable car chargers on Amazon, products that redefine the standard for technologically convenient life, allowing people to enjoy their journeys with happiness and peace of mind!

Lisen's CEO, Hu Weimin, said: "The core of our product development and research is to address customer pain points." The car charger with retractable cables will ensure your devices remain charged and ready for use, which is crucial, especially during long trips, effectively preventing the possibility of missing one of your car charger or cable. The retractable cable also helps keep the interior of your car tidy. At the same time, Lisen offers competitive pricing on Amazon for this series.

Lisen 69W 4-in-1 Square Retractable Car Charger 

Compact, efficient, and incredibly practical, the LISEN 4-in-1 69W Square Retractable Car Charger is perfect for keeping your devices charged on the go. With 69W of power, this charger provides fast charging for multiple devices, including iPhones, Android phones, and more. The retractable cables keep your car organized and your charging needs simple—No more tangled cords or clutter. It's an ideal solution for anyone looking for a compact and reliable charging solution for their daily drives.

Key Features:

Lisen 96W 4-in-1 Retractable Car Charger with Voltage Display and Ambient Light

Take your charging experience to the next level with the LISEN 4-in-1 96W Retractable Car Charger. This premium charger features an advanced voltage display, so you can monitor your car's charging performance at a glance. The added ambient light creates a soft glow that adds a touch of style to your car interior. With 96W of power, this charger ensures quick and efficient charging for all your devices, whether you're on a short commute or a long road trip.

Key Features:

Lisen 69W 4 in1 69W Round Retractable Car Charger

The LISEN 4-in-1 69W Round Retractable Car Charger combines sleek design with practicality. The round shape fits seamlessly into your car's interior while providing the same great performance as the square model. With 69W of power and multiple charging options, this charger is perfect for those who need a reliable and compact solution to keep their devices fully powered while driving. The retractable cables ensure your car stays clutter-free, making this charger both functional and aesthetically pleasing.

Key Features:

LISEN 141W Square Dual Retractable Car Charger

For those who need extra power on the go, the LISEN Dual Cigarette Lighter Splitter Car Charger is the ultimate accessory. With two points of connection, this charger allows you to power multiple devices simultaneously. The retractable cables ensure there's no mess, and the 69W power output ensures a quick charge for all your devices. Plus, with the 20% coupon, it's a steal for anyone looking to upgrade their car charging setup.

Key Features:

About Lisen

Lisen is a leading provider of high-quality consumer electronics, specializing in car chargers, phone accessories, and other innovative products designed to improve the mobile experience. With a focus on advanced technology, durability, and customer satisfaction, LISEN continues to deliver cutting-edge solutions to users worldwide. For more products, visit Lisen Amazon Store.

Contact: LisenMedia, LisenTech@gmail.com 

** The press release content is from PR Newswire. Bastille Post is not involved in its creation. **

Lisen Launched the NO.1 Retractable Car Chargers Series on Amazon

Lisen Launched the NO.1 Retractable Car Chargers Series on Amazon

First-of-its-kind panel includes brain-derived pTau217, pTau181, pTau231, and total tau assays to advance neurodegenerative disease research

FREMONT, Calif., May 15, 2025 /PRNewswire/ -- Alamar Biosciences, a company powering precision proteomics to enable the earliest detection of disease, today announced the expansion of its NULISAseqâ„¢ CNS Disease Panel 120 to include novel assays for brain-derived phosphorylated tau (pTau) proteins. The enhanced panel now features brain-derived pTau217, pTau181, pTau231, and total tau (tTau) protein measured directly from blood samples—delivering unprecedented sensitivity and specificity for the study of neurodegenerative diseases.

Phosphorylated tau has emerged as a critical biomarker for early detection and monitoring of Alzheimer's disease and other tauopathies. The new additions to the CNS Disease 120 Panel are specifically designed to detect brain-derived forms of pTau, overcoming the limitations of current assays that cannot distinguish between peripheral and central tau species. This allows for the simultaneous measurement of two suites of multiple pTaus and tTau species, one specific for brain-derived and one combining brain- and peripheral tissue-derived Tau species.

"Researchers have long sought a reliable, blood-based solution to track brain-derived tau pathology," said Dr. Yuling Luo, CEO, Founder and Chairman of Alamar Biosciences. "By integrating assays for pTau217, pTau181, pTau231, and total tau into our NULISAseq CNS Disease 120 Panel, we are enabling scientists to explore the full spectrum of tau pathology with exceptional sensitivity and throughput. This advancement is poised to accelerate biomarker-driven research and drug development in Alzheimer's Disease and related neurodegenerative disorders."

"The ability to detect brain-derived pTau species directly from blood represents a transformative step in the early detection and monitoring of Alzheimer's Disease (AD) and related disorders," said Nicholas Ashton, Ph.D., Director of Neurodegenerative Biomarker Research at Banner Health. "Until now, we've been unable to differentiate between brain-derived and peripheral pTaus in a multiplexed manner. Recent evidence has underlined the importance of being able to detect brain-derived pTau for greater specificity for AD. Alamar's new CNS panel offers an unprecedented opportunity to further improve the diagnostic accuracy and clinical utilities of these biomarkers, which will dramatically impact patient care and clinical research."

Alamar Biosciences remains committed to partnering with the neuroscience community to unlock biomarker insights that drive earlier diagnosis, patient stratification, and therapeutic monitoring.

For more information about the NULISAseq CNS Disease Panel 120 and Alamar Biosciences' portfolio of proteomic solutions, visit www.alamarbio.com.

About Alamar Biosciences, Inc.

Alamar Biosciences is a privately held life sciences company with a mission to power precision proteomics to enable the earliest detection of disease. The company's proprietary NULISA Platform along with the ARGOâ„¢ HT System work seamlessly with the latest advances in genomics to achieve single digit attomolar detection sensitivity, greatly surpassing the most sensitive protein detection technology on the market today. For more information, please visit alamarbio.com.

** The press release content is from PR Newswire. Bastille Post is not involved in its creation. **

Alamar Biosciences Expands NULISAseq™ CNS Disease Panel 120 with Groundbreaking Blood-Based Brain-Derived pTau Assays

Alamar Biosciences Expands NULISAseq™ CNS Disease Panel 120 with Groundbreaking Blood-Based Brain-Derived pTau Assays

Alamar Biosciences Expands NULISAseq™ CNS Disease Panel 120 with Groundbreaking Blood-Based Brain-Derived pTau Assays

Alamar Biosciences Expands NULISAseq™ CNS Disease Panel 120 with Groundbreaking Blood-Based Brain-Derived pTau Assays

Recommended Articles
Hot · Posts